Category Archives: Science

Science Press Releases & News distributed via EuropaWire

Heidelberg University begins construction of new interdisciplinary research facility for life-inspired molecular systems

(IN BRIEF) Heidelberg University has started construction of its new €70 million Life-inspired Engineering Molecular Systems (LEMS) facility, a landmark interdisciplinary research building that will unite engineering, natural, and life sciences. Located on the Im Neuenheimer Feld campus, LEMS will … Read the full press release

Interactive map from University of Leeds exposes how deforestation accelerates local warming and endangers tropical communities

(IN BRIEF) Researchers at the University of Leeds have developed an interactive map revealing that tropical deforestation can raise local temperatures by up to 5°C, intensifying heat exposure and threatening human health in vulnerable regions. The tool, led by Dr … Read the full press release

Breakthrough study by ICR reveals potential life-saving combination of oncolytic virus and ILP for sarcoma and melanoma patients

(IN BRIEF) Researchers at The Institute of Cancer Research, London, have achieved a breakthrough in the treatment of advanced sarcoma and melanoma through a novel combination of isolated limb perfusion (ILP) and oncolytic virus therapy. In the first clinical trial … Read the full press release

BTRY Secures $5.7 Million to Industrialize Ultra-Thin Solid-State Batteries, Ushering in a New Era of Compact Energy Storage

(IN BRIEF) Swiss start-up BTRY AG has secured $5.7 million in an oversubscribed seed round to industrialize its ultra-thin solid-state batteries, combining rapid charging, high safety, and temperature stability. The funding round, led by Redstone VC with support from Bloomhaus … Read the full press release

TUM Researchers Discover Dendrite Growth Inside Polymer Electrolytes, Redefining Safety Challenges for Solid-State Batteries

(IN BRIEF) Researchers at the Technical University of Munich (TUM) have discovered that lithium dendrites — microscopic metal structures that can cause short circuits and fires — can also form within polymer-based electrolytes, not just at the electrode interface as … Read the full press release

Heritage Meets Innovation as University of Groningen Unveils Bladergroen Building for UCG’s Future Campus

(IN BRIEF) The University of Groningen has named its future University College Groningen headquarters the Bladergroen Building, honoring pioneering child psychologist Wilhelmina Bladergroen. Located at Bloemsingel 1, the building combines the restoration of a 1911 monument with sustainable new construction … Read the full press release

Boehringer Ingelheim and CDR-Life Deepen Collaboration to Advance Autoimmune Drug Development

(IN BRIEF) Boehringer Ingelheim and CDR-Life have expanded their partnership through a global licensing agreement to develop CDR111, a trispecific M-gager® antibody designed to reset the immune system by selectively targeting B cells. The collaboration builds upon their prior success … Read the full press release

Overture Life Secures EIB Support to Boost Automation and Accessibility in Reproductive Healthcare

(IN BRIEF) The European Investment Bank (EIB) has provided a €20 million loan to Overture Life to develop automated and AI-driven technologies for in vitro fertilization (IVF) and egg freezing. The funding supports the company’s R&D, production expansion, and clinical … Read the full press release

From Particle Physics to Birdsong: CERN’s AI Sensors Advance Eco-Innovation in Biodiversity Monitoring

(IN BRIEF) CERN has expanded its AI-based environmental monitoring initiative, “Ambient,” which uses solar-powered audio detectors to identify bird species across its vast campus. Developed in collaboration with the University of Côte d’Azur’s LEAT laboratory, the system employs low-energy EdgeAI … Read the full press release

Brenntag Expands Global Beauty and Care Portfolio Through Exclusive Partnership with Calyxia’s Sustainable Microencapsulation Technology

(IN BRIEF) Brenntag Specialties has entered a global exclusive partnership with Calyxia to distribute its innovative biodegradable microencapsulation technology for Beauty and Care applications. The alliance will expand access to Calyxia’s sustainable microspheres, including CalyCare™ Gel 100—a cold-processable gelling agent … Read the full press release

University of Exeter Research Shows How Legal Flexibility in UNESCO Biospheres Boosts Community-Led Conservation

(IN BRIEF) A University of Exeter study by Dr Tiago de Melo Cartaxo has found that the legal flexibility embedded in UNESCO Biosphere Reserves promotes stronger community participation in environmental conservation. By relying on “soft law” and adaptive governance, these … Read the full press release

Empa-developed technology enables new European satellites to map greenhouse gas emissions with unprecedented precision

(IN BRIEF) Empa researchers have developed advanced emission-mapping technologies that will power the EU’s upcoming CO2M satellite mission, enabling detailed monitoring of greenhouse gases and air pollutants from space. Launching in 2027, the mission will use three satellites equipped with … Read the full press release

Kyowa Kirin and Boehringer Ingelheim Partner to Advance Potential First-in-Class Small Molecule Therapy for Autoimmune Disorders

(IN BRIEF) Boehringer Ingelheim has licensed a pre-clinical small molecule program from Kyowa Kirin to develop a potential first-in-class therapy for autoimmune diseases, a major global health challenge affecting around 10% of the population. The deal grants Boehringer exclusive worldwide … Read the full press release

University of Glasgow Spin-Out Causeway Therapeutics to Advance Phase 3 Trials for Pioneering Tendon Repair Drug

(IN BRIEF) Causeway Therapeutics, a University of Glasgow spin-out, has announced strong Phase 2 results for its novel microRNA therapy, TenoMiR®, used to treat tennis elbow. The study, involving 123 patients across the UK and USA, showed significant improvements in … Read the full press release

Pertussis Rebounds Across Europe as Infant Risk Rises With Falling Immunity and Maternal Vaccine Uptake

Pertussis cases surge: Over 60,000 reported in Europe; infants most at risk. Maternal vaccination expands: Finland, Norway, and UK updated pregnancy vaccine strategies. BioNet advances: Submitted recombinant pertussis vaccine to EMA; secured EU-GMP approval. Nasal vaccine progresses: ILiAD’s BPZE1 granted … Read the full press release

Fresenius Medical Care Advances Precision Nephrology Through Hemodiafiltration and Artificial Intelligence Research

(IN BRIEF) Fresenius Medical Care will present multiple studies at ASN Kidney Week 2025, highlighting how hemodiafiltration (HDF) enhances clinical outcomes and how artificial intelligence is transforming kidney care. One of the featured oral presentations links HDF to a reduced … Read the full press release

Brenntag and Givaudan Join Forces to Bring Innovative Active Ingredients to Thailand’s Beauty and Personal Care Industry

(IN BRIEF) Brenntag has entered a new partnership with Givaudan to distribute active cosmetic ingredients across Thailand’s fast-growing beauty and personal care markets. The agreement expands Brenntag’s specialty portfolio, supported by its Thailand Application and Innovation Centre, which provides formulation … Read the full press release

BioNet Advances Pertussis Vaccine Agenda with EU-GMP Approval, Clinical Collaborations, and New Research Links

BioNet earns EU-GMP certification for its acellular pertussis vaccine, confirming compliance with EU manufacturing and quality standards. Inspection by Ireland’s HPRA supports EMA review of BioNet’s recombinant vaccine candidate VacPertagen. Partnerships expanding: MoU with Indonesia’s Bio Farma to accelerate TdaP … Read the full press release

European Commission Authorises AstraZeneca’s Koselugo for Adult Neurofibromatosis Type 1 Patients After Landmark KOMET Trial

(IN BRIEF) AstraZeneca’s Alexion has secured European Commission approval for Koselugo (selumetinib), the first targeted therapy available to adults with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (PN). The approval is based on the KOMET Phase III trial, … Read the full press release